We believe that regulation of cathepsins, including CatB, CatS, and CatK, in cellular immune responses in patients with periodontitis will be beneficial for reduction of systemic diseases and neurodegenerative diseases in the global aging society. Here, TYRP1 is linked to neurodegenerative disease.